Toxoplasma gondii impairs CX3CL1/fractalkine shedding from mouse cortical neurons, leading to microglia activation

Leonardo Leal de Castro1,2,3, Barbara Gomes da Rosa1, Maria Carolina Peixoto-Rodrigues1

  • 1Laboratório de Biologia Estrutural, Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil.

Microbiology Spectrum
|August 13, 2025
PubMed

Insights

Toxoplasma gondii infection alters neuron signaling, reducing fractalkine (CX3CL1) and potentially worsening brain inflammation and damage. Restoring CX3CL1 may offer therapeutic benefits for neurocognitive deficits.

Area of Science:

  • Neuroscience
  • Immunology
  • Parasitology

Background:

  • Toxoplasmosis, caused by *Toxoplasma gondii*, is a prevalent food-borne illness.
  • Chronic *T. gondii* infection leads to brain microvascular abnormalities, neuroinflammation, and cognitive deficits.
  • The role of infected neurons in orchestrating these pathological processes remains unclear.

Purpose of the Study:

  • To investigate how *T. gondii*-infected neurons signal to influence neurovascular and neuroinflammatory responses.
  • To identify key molecules released by infected neurons that contribute to brain pathology.
  • To explore the therapeutic potential of targeting neuron-derived signaling molecules.

Main Methods:

  • Primary mouse cortical neurons were infected with *T. gondii* (ME49 strain).
  • Proteome arrays were used to identify signaling molecules in conditioned neuronal media.
  • ELISA, RT-qPCR, and immunoblotting validated target molecules in vitro and in vivo.
  • Microglial responses to recombinant fractalkine (CX3CL1) were assessed.

Main Results:

  • Infected neurons exhibited altered secretion of nine key molecules, including VEGFA, IGFBPs, PDGF-AA, CCLs, and CX3CL1.
  • CX3CL1 secretion was reduced in infected neurons, while its receptor (CX3CR1) was upregulated in vivo.
  • Recombinant CX3CL1 modulated microglial activation markers (arginase-1 and iNOS), suggesting a shift towards a pro-resolutive state.
  • Gene expression changes in infected neurons did not always correlate with protein level alterations.

Conclusions:

  • *T. gondii*-infected neurons release specific signaling molecules that drive neuroinflammation and vascular changes.
  • Reduced CX3CL1 secretion by infected neurons may contribute to sustained neuroinflammation and cognitive impairment.
  • CX3CL1 signaling is a critical regulator of neuroinflammatory responses in toxoplasmosis.
  • Targeting CX3CL1 presents a potential therapeutic strategy to mitigate neurocognitive damage in toxoplasmosis.